GlassScriptPhysician profile
Stormy Lopez
NPI 1215611421
$2,434.02
in general payments reported to CMS, 2019-2025
12 companies · $1,133 in 2025
The $1,133 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $515 · 2024: $786 · 2025: $1,133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,067 · Education: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,067.07 |
| Education | $366.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avadel Cns Pharmaceuticals, LLC | $898.75 | 2023-2025 | Lumryz |
| Jazz Pharmaceuticals INC. | $630.91 | 2023-2025 | |
| Harmony Biosciences LLC | $322.30 | 2023-2025 | Wakix |
| Axsome Therapeutics, INC. | $177.14 | 2025 | Sunosi |
| Sk Life Science, INC. | $100.73 | 2023-2024 | Xcopri |
| Idorsia Pharmaceuticals US INC | $90.07 | 2023-2024 | Quviviq |
| Inspire Medical Systems, INC. | $67.59 | 2023-2024 | Inspire |
| Zoll Respicardia, INC. | $37.33 | 2023 | Remede System |
| Azurity Pharmaceuticals, INC. | $34.37 | 2025 | Horizant |
| Noctrix Health, INC. | $30.98 | 2025 | Nidra |
| Lilly USA, LLC | $26.43 | 2025 | Zepbound |
| Itamar Medical INC | $17.42 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stormy Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.